The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I,
##STR00001## wherein the substituents are as defined in the
specification, as well as their use as pharmaceuticals.The compounds of
the invention are particularly suited for treating neurological disorders
such as epilepsy.